Annual Net Income
-$118.51 M
-$33.04 M-38.65%
31 December 2023
Summary:
Cara Therapeutics annual net profit is currently -$118.51 million, with the most recent change of -$33.04 million (-38.65%) on 31 December 2023. During the last 3 years, it has fallen by -$126.92 million (-1509.19%). CARA annual net income is now -1509.19% below its all-time high of $8.41 million, reached on 31 December 2020.CARA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$12.48 M
+$7.54 M+37.67%
30 September 2024
Summary:
Cara Therapeutics quarterly net profit is currently -$12.48 million, with the most recent change of +$7.54 million (+37.67%) on 30 September 2024. Over the past year, it has increased by +$15.56 million (+55.49%). CARA quarterly net income is now -115.81% below its all-time high of $78.91 million, reached on 31 December 2020.CARA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$95.53 M
+$15.56 M+14.00%
30 September 2024
Summary:
Cara Therapeutics TTM net profit is currently -$95.53 million, with the most recent change of +$15.56 million (+14.00%) on 30 September 2024. Over the past year, it has increased by +$20.99 million (+18.01%). CARA TTM net income is now -500.52% below its all-time high of $23.85 million, reached on 30 September 2021.CARA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.6% | +55.5% | +18.0% |
| 3 y3 years | -1509.2% | -1131.6% | -500.5% |
| 5 y5 years | -60.1% | +62.0% | +2.9% |
CARA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1509.2% | at low | -1131.6% | +62.6% | -500.5% | +22.1% |
| 5 y | 5 years | -1509.2% | at low | -115.8% | +62.6% | -500.5% | +22.1% |
| alltime | all time | -1509.2% | at low | -115.8% | +62.6% | -500.5% | +22.1% |
Cara Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.48 M(-37.7%) | -$95.53 M(-14.0%) |
| June 2024 | - | -$20.02 M(-34.8%) | -$111.08 M(-9.4%) |
| Mar 2024 | - | -$30.70 M(-5.1%) | -$122.54 M(+3.4%) |
| Dec 2023 | -$118.51 M(+38.7%) | -$32.34 M(+15.4%) | -$118.51 M(+1.7%) |
| Sept 2023 | - | -$28.03 M(-11.0%) | -$116.52 M(+4.3%) |
| June 2023 | - | -$31.48 M(+18.1%) | -$111.66 M(+32.3%) |
| Mar 2023 | - | -$26.66 M(-12.1%) | -$84.39 M(-1.3%) |
| Dec 2022 | -$85.47 M(-3.4%) | -$30.34 M(+30.9%) | -$85.47 M(-3.4%) |
| Sept 2022 | - | -$23.18 M(+451.1%) | -$88.52 M(+33.4%) |
| June 2022 | - | -$4.21 M(-84.8%) | -$66.35 M(-28.6%) |
| Mar 2022 | - | -$27.75 M(-16.9%) | -$92.89 M(+5.0%) |
| Dec 2021 | -$88.44 M(-1151.6%) | -$33.38 M(+3195.4%) | -$88.44 M(-470.8%) |
| Sept 2021 | - | -$1.01 M(-96.7%) | $23.85 M(+185.5%) |
| June 2021 | - | -$30.75 M(+31.9%) | $8.35 M(-40.5%) |
| Mar 2021 | - | -$23.30 M(-129.5%) | $14.03 M(+66.8%) |
| Dec 2020 | $8.41 M(-107.9%) | $78.91 M(-578.0%) | $8.41 M(-108.5%) |
| Sept 2020 | - | -$16.51 M(-34.1%) | -$99.11 M(-14.1%) |
| June 2020 | - | -$25.07 M(-13.3%) | -$115.44 M(+1.9%) |
| Mar 2020 | - | -$28.92 M(+1.1%) | -$113.33 M(+6.5%) |
| Dec 2019 | -$106.37 M(+43.7%) | -$28.61 M(-12.9%) | -$106.37 M(+8.1%) |
| Sept 2019 | - | -$32.84 M(+43.0%) | -$98.41 M(+15.8%) |
| June 2019 | - | -$22.96 M(+4.6%) | -$84.97 M(+7.3%) |
| Mar 2019 | - | -$21.96 M(+6.3%) | -$79.21 M(+7.0%) |
| Dec 2018 | -$74.01 M | -$20.65 M(+6.5%) | -$74.01 M(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$19.40 M(+12.8%) | -$67.54 M(+11.5%) |
| June 2018 | - | -$17.19 M(+2.5%) | -$60.58 M(+15.0%) |
| Mar 2018 | - | -$16.77 M(+18.3%) | -$52.69 M(-9.4%) |
| Dec 2017 | -$58.13 M(+1.5%) | -$14.18 M(+13.9%) | -$58.13 M(-11.8%) |
| Sept 2017 | - | -$12.44 M(+33.8%) | -$65.92 M(+1.4%) |
| June 2017 | - | -$9.30 M(-58.1%) | -$65.02 M(-5.5%) |
| Mar 2017 | - | -$22.20 M(+1.1%) | -$68.79 M(+20.1%) |
| Dec 2016 | -$57.28 M(+132.0%) | -$21.97 M(+90.4%) | -$57.28 M(+27.7%) |
| Sept 2016 | - | -$11.54 M(-11.7%) | -$44.84 M(+17.7%) |
| June 2016 | - | -$13.07 M(+22.3%) | -$38.08 M(+24.1%) |
| Mar 2016 | - | -$10.69 M(+12.2%) | -$30.69 M(+24.3%) |
| Dec 2015 | -$24.69 M(+39.1%) | -$9.53 M(+99.1%) | -$24.69 M(+27.7%) |
| Sept 2015 | - | -$4.79 M(-15.8%) | -$19.33 M(-8.3%) |
| June 2015 | - | -$5.68 M(+21.2%) | -$21.09 M(+10.7%) |
| Mar 2015 | - | -$4.69 M(+12.4%) | -$19.05 M(+7.4%) |
| Dec 2014 | -$17.75 M(+347.8%) | -$4.17 M(-36.3%) | -$17.75 M(+13.3%) |
| Sept 2014 | - | -$6.54 M(+79.6%) | -$15.67 M(+14.4%) |
| June 2014 | - | -$3.65 M(+7.7%) | -$13.70 M(+190.5%) |
| Mar 2014 | - | -$3.38 M(+61.6%) | -$4.71 M(+19.0%) |
| Dec 2013 | -$3.96 M(-36.8%) | -$2.09 M(-54.3%) | -$3.96 M(+8.1%) |
| Sept 2013 | - | -$4.58 M(-185.7%) | -$3.67 M(-503.9%) |
| June 2013 | - | $5.34 M(-302.8%) | $908.00 K(-120.5%) |
| Mar 2013 | - | -$2.63 M(+46.5%) | -$4.43 M(+146.5%) |
| Dec 2012 | -$6.27 M(-36.0%) | -$1.80 M | -$1.80 M |
| Dec 2011 | -$9.81 M | - | - |
FAQ
- What is Cara Therapeutics annual net profit?
- What is the all time high annual net income for Cara Therapeutics?
- What is Cara Therapeutics annual net income year-on-year change?
- What is Cara Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Cara Therapeutics?
- What is Cara Therapeutics quarterly net income year-on-year change?
- What is Cara Therapeutics TTM net profit?
- What is the all time high TTM net income for Cara Therapeutics?
- What is Cara Therapeutics TTM net income year-on-year change?
What is Cara Therapeutics annual net profit?
The current annual net income of CARA is -$118.51 M
What is the all time high annual net income for Cara Therapeutics?
Cara Therapeutics all-time high annual net profit is $8.41 M
What is Cara Therapeutics annual net income year-on-year change?
Over the past year, CARA annual net profit has changed by -$33.04 M (-38.65%)
What is Cara Therapeutics quarterly net profit?
The current quarterly net income of CARA is -$12.48 M
What is the all time high quarterly net income for Cara Therapeutics?
Cara Therapeutics all-time high quarterly net profit is $78.91 M
What is Cara Therapeutics quarterly net income year-on-year change?
Over the past year, CARA quarterly net profit has changed by +$15.56 M (+55.49%)
What is Cara Therapeutics TTM net profit?
The current TTM net income of CARA is -$95.53 M
What is the all time high TTM net income for Cara Therapeutics?
Cara Therapeutics all-time high TTM net profit is $23.85 M
What is Cara Therapeutics TTM net income year-on-year change?
Over the past year, CARA TTM net profit has changed by +$20.99 M (+18.01%)